Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: absence of evidence of threshold

被引:0
|
作者
Little, MP [1 ]
Muirhead, CR [1 ]
机构
[1] Natl Radiol Protect Board, Didcot OX11 0RQ, Oxon, England
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purposes: To investigate the evidence for a threshold in the cancer dose-response curve. Materials and methods: Japanese atomic bomb survivor cancer mortality data, based on follow-up to 1990, was used, laking account of random errors in DS86 dose estimates. Results: For all solid cancers analysed together, there is a significant positive dose response (two-sided P<0.05) if all survivors who received <0.5 Sv are considered, but the significance vanishes if doses of <0.2 Sv are considered; the same is also true for leukaemia. For solid cancer mortality there is no indication of curvilinearity in the dose response: no statistically significant improvement in fit to a linear relative risk model is provided by addition of quadratic or threshold dose terms. If a relative risk model with a threshold (the dose response is assumed linear above the threshold) is fitted to solid cancer mortality data, the best estimate of the threshold is <0.00 Sv (95% CI <0.00-0.13). If a linear-quadratic-threshold model is used the best estimate of the threshold is <0.00 Sv (95% CI <0.00-0.15). For leukaemia mortality there is highly statistically significant upward curvature in the dose response. In particular, ifa relative risk model with a threshold (the dose response is assumed linear above the threshold) is fitted to the leukaemia data, the best estimate of the threshold is 0.16 Sv (95% CI 0.05-0.40) (two-sided P=0.001 for test of departure of threshold from 0). However, there is no evidence for a threshold effect (two-sided p=0.16)when a quadratic term is included in the dose response: the best estimate of threshold in this case is 0.09 Sv (95% CI <0.00-0.29). Moreover, addition of a quadratic term improves the fit of a linear-threshold model at borderline levels of statistical significance (two-sided P=0.07). Therefore, the most parsimonious description of the leukaemia dose response is provided by a linear-quadratic function of dose. Conclusions. There is no evidence of threshold-type departures from the linear-quadratic dose response either for solid rumours or for leukaemia in the Japanese atomic bomb survivor mortality data.
引用
收藏
页码:471 / 480
页数:10
相关论文
共 50 条
  • [21] Dietary factors and cancer mortality among atomic-bomb survivors
    Sauvaget, C
    Kasagi, F
    Waldren, CA
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 551 (1-2) : 145 - 152
  • [22] Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors
    Zhang, W
    Muirhead, CR
    Hunter, N
    JOURNAL OF RADIOLOGICAL PROTECTION, 2005, 25 (04) : 393 - 404
  • [23] MORTALITY AMONG ATOMIC-BOMB SURVIVORS
    SHIMIZU, Y
    KATO, H
    SCHULL, WJ
    JOURNAL OF RADIATION RESEARCH, 1991, 32 : 212 - 230
  • [24] MORTALITY IN CHILDREN OF ATOMIC BOMB SURVIVORS AND CONTROLS
    NEEL, JV
    KATO, H
    SCHULL, WJ
    GENETICS, 1974, 76 (02) : 311 - 326
  • [25] The Offspring of Atomic Bomb Survivors: Cancer and Non-Cancer Mortality and Cancer Incidence
    Suyama, Akihiko
    Izumi, Shizue
    Koyama, Kojiro
    Sakata, Ritsu
    Nishi, Nobuo
    Soda, Midori
    Grant, Eric J.
    Shimizu, Yukiko
    Furukawa, Kyoji
    Cullings, Harry M.
    Kasagi, Fumiyoshi
    Kodama, Kazunori
    RADIATION HEALTH RISK SCIENCES, 2009, : 57 - +
  • [26] Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb
    Brenner, DJ
    RADIATION RESEARCH, 1996, 145 (04) : 501 - 507
  • [27] Accounting for Neutron Exposure in the Japanese Atomic Bomb Survivors
    Cullings, Harry M.
    Pierce, Donald A.
    Kellerer, Albrecht M.
    RADIATION RESEARCH, 2014, 182 (06) : 587 - 598
  • [28] Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009
    Brenner, A., V
    Preston, D. L.
    Sakata, R.
    Cologne, J.
    Sugiyama, H.
    Utada, M.
    Cahoon, E. K.
    Grant, E.
    Mabuchi, K.
    Ozasa, K.
    RADIATION RESEARCH, 2022, 197 (05) : 491 - 508
  • [29] Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors
    Hafner, Luana
    Walsh, Linda
    Ruehm, Werner
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2024, 100 (01) : 61 - 71
  • [30] Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University
    Matsuura, M
    Hoshi, M
    Hayakawa, N
    Shimokata, H
    Ohtaki, M
    Ikeuchi, M
    Kasagi, F
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1997, 71 (05) : 603 - 611